Abstract
There are currently no consistent objective biochemical markers of alcohol abuse and alcoholism. Development of reliable diagnostic biomarkers that permit accurate assessment of alcohol intake and patterns of drinking is of prime importance to treatment and research fields. Diagnostic biomarker development in other diseases has demonstrated the utility of both open, systems biology, screening for biomarkers and more rational focused efforts on specific biomolecules or families of biomolecules. Long-term alcohol consumption leads to altered inflammatory cell and adaptive immune responses with associated pathologies and increased incidence of infections. This has led researchers to focus attention on identifying cytokine biomarkers in models of alcohol abuse. Alcohol is known to alter cytokine levels in plasma and a variety of tissues including lung, liver, and very importantly brain. A number of cytokine biomarker candidates have been identified, including: tumor necrosis factor-alpha, interleukin (IL)-1-alpha, IL-1-beta, IL-6, IL-8, IL-12, and monocyte chemoattractant protein-1. This is an emerging and potentially exciting avenue of research in that circulating cytokines may contribute to diagnostic biomarker panels, and a combination of multiple biomarkers may significantly increase the sensitivity and specificity of the biochemical tests aiding reliable and accurate detection of excessive alcohol intake.
Similar content being viewed by others
References
Anton RF, Lieber C, Tabakoff B (2002) Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study. Alcohol Clin Exp Res 26:1215–1222
Bauer S, Cepok S, Todorova-Rudolph A, Nowak M, Koller M, Lorenz R, Oertel WH, Rosenow F, Hemmer B, Hamer HM (2009) Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res 86:82–88
Berner MM, Bentele M, Kriston L, Manz C, Clement HW, Harter M, Mundle G (2006) DOVER and QUVER-new marker combinations to detect and monitor at-risk drinking. Alcohol Clin Exp Res 30:1372–1380
Biermann T, Bonsch D, Reulbach U, Kornhuber J, Bleich S (2007) Dopamine and N-methyl-D-aspartate receptor expression in peripheral blood of patients undergoing alcohol withdrawal. J Neural Transm 114:1081–1084
Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69:89–95
Bird GL, Sheron N, Goka AK, Alexander GJ, Williams RS (1990) Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 112:917–920
Bleich S, Hillemacher T (2009) Homocysteine, alcoholism and its molecular networks. Pharmacopsychiatry 42(Suppl 1):S102–S109
Bradford BU, O'Connell TM, Han J, Kosyk O, Shymonyak S, Ross PK, Winnike J, Kono H, Rusyn I (2008) Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol Appl Pharmacol 232:236–243
Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR (2007) AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 31:1208–1217
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA (1998) The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 158:1789–1795
Choi C, Jeong JH, Jang JS, Choi K, Lee J, Kwon J, Choi KG, Lee JS, Kang SW (2008) Multiplex analysis of cytokines in the serum and cerebrospinal fluid of patients with Alzheimer's disease by color-coded bead technology. J Clin Neurol 4:84–88
Comasco E, Nordquist N, Leppert J, Oreland L, Kronstrand R, Alling C, Nilsson KW (2009) Adolescent alcohol consumption: biomarkers PEth and FAEE in relation to interview and questionnaire data. J Stud Alcohol Drugs 70:797–804
Conigrave KM, Degenhardt LJ, Whitfield JB, Saunders JB, Helander A, Tabakoff B (2002) CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res 26:332–339
Conigrave KM, Davies P, Haber P, Whitfield JB (2003) Traditional markers of excessive alcohol use. Addiction 98(Suppl 2):31–43
Crews FT, Nixon K (2009) Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol Alcohol 44:115–127
Crews FT, Bechara R, Brown LA, Guidot DM, Mandrekar P, Oak S, Qin L, Szabo G, Wheeler M, Zou J (2006a) Cytokines and alcohol. Alcohol Clin Exp Res 30:720–730
Crews FT, Mdzinarishvili A, Kim D, He J, Nixon K (2006b) Neurogenesis in adolescent brain is potently inhibited by ethanol. Neuroscience 137:437–445
Das SK, Dhanya L, Vasudevan DM (2008) Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 68:81–92
De GN, Donadio G, Chiarotti M (2007) The reliability of fatty acid ethyl esters (FAEE) as biological markers for the diagnosis of alcohol abuse. J Anal Toxicol 31:93–97
Diaz LE, Montero A, Gonzalez-Gross M, Vallejo AI, Romeo J, Marcos A (2002) Influence of alcohol consumption on immunological status: a review. Eur J Clin Nutr 56(Suppl 3):S50–S53
Ewing JA (1984) Detecting alcoholism. The CAGE questionnaire. JAMA 252:1905–1907
Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, Veech RL (1990) Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 14:255–259
Freeman WM, Gooch RS, Lull ME, Worst TJ, Walker SJ, Xu AS, Green H, Pierre PJ, Grant KA, Vrana KE (2006) Apo-aii is an elevated biomarker of chronic non-human primate ethanol self-administration. Alcohol Alcohol 41:300–305
Fujimoto M, Uemura M, Nakatani Y, Tsujita S, Hoppo K, Tamagawa T, Kitano H, Kikukawa M, Ann T, Ishii Y, Kojima H, Sakurai S, Tanaka R, Namisaki T, Noguchi R, Higashino T, Kikuchi E, Nishimura K, Takaya A, Fukui H (2000) Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 24:48S–54S
Fuller RK, Lee KK, Gordis E (1988) Validity of self-report in alcoholism research: results of a Veterans Administration Cooperative Study. Alcohol Clin Exp Res 12:201–205
Ghosh P, Hale EA, Lakshman MR (2001) Plasma sialic-acid index of apolipoprotein J (SIJ): a new alcohol intake marker. Alcohol 25:173–179
Golka K, Wiese A (2004) Carbohydrate-deficient transferrin (CDT)–a biomarker for long-term alcohol consumption. J Toxicol Environ Health B Crit Rev 7:319–337
Gonzalez-Quintela A, Campos J, Loidi L, Quinteiro C, Perez LF, Gude F (2008) Serum TNF-alpha levels in relation to alcohol consumption and common TNF gene polymorphisms. Alcohol 42:513–518
Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ (2007) Biochemical markers of alcoholism. Clin Chem Lab Med 45:953–961
Hansson P, Caron M, Johnson G, Gustavsson L, Alling C (1997) Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 21:108–110
Harasymiw J, Bean P (2001) The combined use of the early detection of alcohol consumption (EDAC) test and carbohydrate-deficient transferrin to identify heavy drinking behaviour in males. Alcohol Alcohol 36:349–353
He J, Crews FT (2008) Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol 210:349–358
Heinz R, Waltenbaugh C (2007) Ethanol consumption modifies dendritic cell antigen presentation in mice. Alcohol Clin Exp Res 31:1759–1771
Helander A (2003) Biological markers in alcoholism. J Neural Transm Suppl 66:15–32
Helander A, Eriksson CJ (2002) Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcohol Clin Exp Res 26:1070–1077
Hock B, Schwarz M, Domke I, Grunert VP, Wuertemberger M, Schiemann U, Horster S, Limmer C, Stecker G, Soyka M (2005) Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 100:1477–1486
Javors MA, Johnson BA (2003) Current status of carbohydrate deficient transferrin, total serum sialic acid, sialic acid index of apolipoprotein J and serum beta-hexosaminidase as markers for alcohol consumption. Addiction 98(Suppl 2):45–50
Jayasinghe R, Gianutsos G, Hubbard AK (1992) Ethanol-induced suppression of cell-mediated immunity in the mouse. Alcohol Clin Exp Res 16:331–335
Kapoor A, Kraemer KL, Smith KJ, Roberts MS, Saitz R (2009) Cost-effectiveness of screening for unhealthy alcohol use with %carbohydrate deficient transferrin: results from a literature-based decision analytic computer model. Alcohol Clin Exp Res 33:1440–1449
Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI (1991) Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267–276
Kissack JC, Bishop J, Roper AL (2008) Ethylglucuronide as a biomarker for ethanol detection. Pharmacotherapy 28:769–781
Koch H, Meerkerk GJ, Zaat JO, Ham MF, Scholten RJ, Assendelft WJ (2004) Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review. Alcohol Alcohol 39:75–85
Korzec A, de Bruijn C, van Lambalgen M (2005) The Bayesian alcoholism test had better diagnostic properties for confirming diagnosis of hazardous and harmful alcohol use. J Clin Epidemiol 58:1024–1032
Korzec S, Korzec A, Conigrave K, Gisolf J, Tabakoff B (2009) Validation of the Bayesian alcoholism test compared to single biomarkers in detecting harmful drinking. Alcohol Alcohol 44:398–402
Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A (2007) Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: relationship with ethanol intake and liver disease. Cytometry B Clin Cytom 72:408–415
Le Moine O, Soupison T, Sogni P, Marchant A, Moreau R, Hadengue A, Goldman M, Deviere J, Lebrec D (1995) Plasma endotoxin and tumor necrosis factor-alpha in the hyperkinetic state of cirrhosis. J Hepatol 23:391–395
Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1):S232–S240
Mandrekar P, Catalano D, Dolganiuc A, Kodys K, Szabo G (2004) Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production. J Immunol 173:3398–3407
Marcos M, Pastor I, Gonzalez-Sarmiento R, Laso FJ (2008) Interleukin-10 gene polymorphism is associated with alcoholism but not with alcoholic liver disease. Alcohol Alcohol 43:523–528
Miller PM, Spies C, Neumann T, Javors MA, Hoyumpa AM, Roache J, Webb A, Kashi M, Sharkey FE, Anton RF, Egan BM, Basile J, Nguyen S, Fleming MF, Dillie KS (2006) Alcohol biomarker screening in medical and surgical settings. Alcohol Clin Exp Res 30:185–193
Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, Connor JR (2009) A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72:14–19
Molina PE, McNurlan M, Rathmacher J, Lang CH, Zambell KL, Purcell J, Bohm RP, Zhang P, Bagby GJ, Nelson S (2006) Chronic alcohol accentuates nutritional, metabolic, and immune alterations during asymptomatic simian immunodeficiency virus infection. Alcohol Clin Exp Res 30:2065–2078
Niemela O (2007) Biomarkers in alcoholism. Clin Chim Acta 377:39–49
Nomura F, Tomonaga T, Sogawa K, Wu D, Ohashi T (2007) Application of proteomic technologies to discover and identify biomarkers for excessive alcohol consumption: a review. J Chromatogr B Analyt Technol Biomed Life Sci 855:35–41
Pernanen K (1974) Validity of survey data on alcohol use. In: Gibbons RJ et al (eds) Research advances in alcohol and drug problems. Howard Cappell, New York, pp 355–374
Perry VH (2004) The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 18:407–413
Ray S et al (2007) Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 13:1359–1362
Rinck D, Frieling H, Freitag A, Hillemacher T, Bayerlein K, Kornhuber J, Bleich S (2007) Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol dependent patients. Drug Alcohol Depend 89:60–65
Romeo J, Warnberg J, Nova E, Diaz LE, Gomez-Martinez S, Marcos A (2007) Moderate alcohol consumption and the immune system: a review. Br J Nutr 98(Suppl 1):S111–S115
Shau H, Chandler GS, Whitelegge JP, Gornbein JA, Faull KF, Chang HR (2003) Proteomic profiling of cancer biomarkers. Brief Funct Genomic Proteomic 2:147–158
Sheron N, Bird G, Goka J, Alexander G, Williams R (1991) Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis. Clin Exp Immunol 84:449–453
Sinha S, Patil SA, Jayalekshmy V, Satishchandra P (2008) Do cytokines have any role in epilepsy? Epilepsy Res 82:171–176
Spira A, Beane JE, Shah V, Steiling K, Liu G, Schembri F, Gilman S, Dumas YM, Calner P, Sebastiani P, Sridhar S, Beamis J, Lamb C, Anderson T, Gerry N, Keane J, Lenburg ME, Brody JS (2007) Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 13:361–366
Stephanson N, Helander A, Beck O (2007) Alcohol biomarker analysis: simultaneous determination of 5-hydroxytryptophol glucuronide and 5-hydroxyindoleacetic acid by direct injection of urine using ultra-performance liquid chromatography-tandem mass spectrometry. J Mass Spectrom 42:940–949
Szabo G (1999) Consequences of alcohol consumption on host defence. Alcohol Alcohol 34:830–841
Szabo G, Mandrekar P (2009) A recent perspective on alcohol, immunity, and host defense. Alcohol Clin Exp Res 33:220–232
Szabo G, Catalano D, White B, Mandrekar P (2004) Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells. Alcohol Clin Exp Res 28:824–828
Taracha E, Habrat B, Wozniak P, Walkowiak J, Szukalski B (2001) The activity of beta-hexosaminidase (uHex) and gamma-glutamyl-transferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: I. Alcohol-dependent subjects. World J Biol Psychiatry 2:184–189
Tonnesen H, Kaiser AH, Nielsen BB, Pedersen AE (1992) Reversibility of alcohol-induced immune depression. Br J Addict 87:1025–1028
Vuorela P, Sarkola T, Alfthan H, Halmesmaki E (2002) Hepatocyte growth factor, epidermal growth factor, and placenta growth factor concentrations in peripheral blood of pregnant women with alcohol abuse. Alcohol Clin Exp Res 26:682–687
Walker SJ, Grant KA (2006) Peripheral blood alpha-synuclein mRNA levels are elevated in cynomolgus monkeys that chronically self-administer ethanol. Alcohol 38:1–4
Xiao Z, Prieto D, Conrads TP, Veenstra TD, Issaq HJ (2005) Proteomic patterns: their potential for disease diagnosis. Mol Cell Endocrinol 230:95–106
Acknowledgments
This work was supported by NIH grant R01AA016613 (KEV). The authors thank Mr. Steven Swavely for his editorial contribution.
Disclaimers
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by NIH grant R01AA016613 (KEV).
Rights and permissions
About this article
Cite this article
Achur, R.N., Freeman, W.M. & Vrana, K.E. Circulating Cytokines as Biomarkers of Alcohol Abuse and Alcoholism. J Neuroimmune Pharmacol 5, 83–91 (2010). https://doi.org/10.1007/s11481-009-9185-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-009-9185-z